Hunan Kelun Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Subsidiary
- Established
- 2001-05-15
- Employees
- -
- Market Cap
- -
- Website
- http://www.kelun.com
Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Not Applicable
1 (33.3%)A Phase I Study of KLA318-2 Nanocrystal Injection
Not Applicable
Not yet recruiting
- Conditions
- Healthy Participants
- Interventions
- Drug: KLA318-2 Nanocrystal Injection
- First Posted Date
- 2025-09-12
- Last Posted Date
- 2025-09-12
- Lead Sponsor
- Hunan Kelun Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT07171034
- Locations
- 🇨🇳
The first affiliated hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital), Jinan, Shandong, China
Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Bioequivalence Study
- Interventions
- First Posted Date
- 2017-02-10
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- Hunan Kelun Pharmaceutical Co., Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT03050164
Bioequivalence Study of Gefitinib Tablets Under Fed Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2017-02-10
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- Hunan Kelun Pharmaceutical Co., Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT03050177
News
No news found